Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
- 1 January 1991
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 12 (1), 19-27
- https://doi.org/10.1016/0165-6147(91)90484-a
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardiumJournal of Pharmacy and Pharmacology, 1990
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesteraseThe American Journal of Cardiology, 1989
- Relationships of secretagogue-induced cAMP accumulation and acid secretion in elutriated rat gastric parietal cellsJournal of Pharmacological Methods, 1988
- Mechanism of action of methylxanthines in asthmaJournal of Allergy and Clinical Immunology, 1988
- New cardiotonic agents — a promising approach for treatment of heart failureTrends in Pharmacological Sciences, 1988
- Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterasesJournal of Molecular and Cellular Cardiology, 1987
- Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activationJournal of Allergy and Clinical Immunology, 1986
- Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship applicationJournal of Medicinal Chemistry, 1985